❌

Normal view

Received before yesterday

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

11 December 2025 at 16:09
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Β© Mike Blake/Reuters

Eli Lilly company offices in San Diego. The company reported results of retatrutide, its next-generation weight-loss drug.

Why Some Doctors Say There Are Cancers That Shouldn’t Be Treated

8 December 2025 at 12:54
Statistics show a clear spike in eight cancers in younger people, but that has brought a debate over whether many cases ever needed to be found.

Β© Michael Macor/San Francisco Chronicle, via Getty Images

An image of a patient’s prostate. Patients in the early stages of prostate cancer and other types of cancer might safely wait to see if the disease progresses.

After Trump’s MRI Claim, His Doctor’s Memo Offers Little Clarity

2 December 2025 at 14:16
While the president said he had an M.R.I. exam, a physician’s memo released by the White House was less specific.

Β© Tierney L. Cross/The New York Times

The statement, by Dr. Sean P. Barbabella, said the tests on President Trump’s cardiovascular system and abdominal region showed the president β€œremains in excellent overall health.”

GLP-1 Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

25 November 2025 at 08:07
The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

Β© Hollie Adams/Reuters

A trial of semaglutide, the miracle drug branded as Ozempic and Wegovy for diabetes and weight loss, failed to find any effect of the drug on cognition and functioning in people with mild cognitive impairment or dementia.

For Parents of Children With Autism, There Are No Easy Answers

11 November 2025 at 05:01
Two reporters wanted to witness firsthand how doctors and families navigate mixed messages and unproven claims.

Β© Ilana Panich-Linsman for The New York Times

Dr. Audrey Brumback, a pediatric neurologist, evaluating a patient at her clinic in Austin, Texas.

Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future

8 November 2025 at 17:57
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk.

Β© Andrew Kelly/Reuters

Merck, which first introduced statins to the world nearly 40 years ago, announced that its new pill helped reduce heart attack and stroke rates in high risk patients by 20 percent in a year.

The Editor Got a Letter From β€˜Dr. B.S.’ So Did a Lot of Other Editors.

4 November 2025 at 12:18
The rise of artificial intelligence has produced serial writers to science and medical journals, most likely using chatbots to boost the number of citations they’ve published.

Β© Eva Manez/Reuters

A research scientist who published a paper in a scientific journal about controlling mosquito-borne malaria infections was asked to rebut a letter to the editor sent by a scientist who had suddenly become improbably prolific starting in 2025.

The Editor Got a Letter From β€˜Dr. B.S.’ So Did a Lot of Other Editors.

4 November 2025 at 12:18
The rise of artificial intelligence has produced serial writers to science and medical journals, most likely using chatbots to boost the number of citations they’ve published.

Β© Eva Manez/Reuters

A research scientist who published a paper in a scientific journal about controlling mosquito-borne malaria infections was asked to rebut a letter to the editor sent by a scientist who had suddenly become improbably prolific starting in 2025.

Vision Restored Using Prosthetic Retinal Implant

20 October 2025 at 08:00
The device could help a million people with a severe form of macular degeneration to be able to see enough to read.

Β© Science Corporation

A camera attached to glasses transmits the image on the right to a patient’s artificial retina.
❌